Clonal hematopoiesis of indeterminate potential and its impact on patient trajectories after stem cell transplantation.
Derek S ParkAfua A AkuffoDavid E MuenchH Leighton GrimesPearlie K Epling-BurnettePhilip K MainiAlexander R A AndersonMichael B BonsallPublished in: PLoS computational biology (2019)
Clonal hematopoiesis of indeterminate potential (CHIP) is a recently identified process where older patients accumulate distinct subclones defined by recurring somatic mutations in hematopoietic stem cells. CHIP's implications for stem cell transplantation have been harder to identify due to the high degree of mutational heterogeneity that is present within the genetically distinct subclones. In order to gain a better understanding of CHIP and the impact of clonal dynamics on transplantation outcomes, we created a mathematical model of clonal competition dynamics. Our analyses highlight the importance of understanding competition intensity between healthy and mutant clones. Importantly, we highlight the risk that CHIP poses in leading to dominance of precancerous mutant clones and the risk of donor derived leukemia. Furthermore, we estimate the degree of competition intensity and bone marrow niche decline in mice during aging by using our modeling framework. Together, our work highlights the importance of better characterizing the ecological and clonal composition in hematopoietic donor populations at the time of stem cell transplantation.
Keyphrases
- stem cell transplantation
- bone marrow
- high dose
- high throughput
- stem cells
- circulating tumor cells
- human health
- mesenchymal stem cells
- high intensity
- wild type
- single cell
- risk assessment
- depressive symptoms
- cell therapy
- metabolic syndrome
- climate change
- acute myeloid leukemia
- type diabetes
- dna methylation
- gene expression
- case report
- high fat diet induced
- skeletal muscle
- ultrasound guided